How severe is CVE-2023-30437?

CVE-2023-30437 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.

Is CVE-2023-30437 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-30437?

CVE-2023-30437 primarily affects Ibm Security Guardium. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2023-30437?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2023-30437 published?

CVE-2023-30437 was published on 2023-08-27 and last updated on 2026-06-17.

CVE-2023-30437

CVE-2023-30437 is a medium-severity vulnerability in Ibm Security Guardium with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 3.x base score 5.3)
EPSS exploit prediction: 1% (41st percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Ibm Security Guardium
Published: 2023-08-27
Last modified: 2026-06-17

Description

IBM Security Guardium 11.3, 11.4, and 11.5 could allow an unauthorized user to enumerate usernames by sending a specially crafted HTTP request. IBM X-Force ID: 252293.

Frequently asked questions

What is CVE-2023-30437?: IBM Security Guardium 11.3, 11.4, and 11.5 could allow an unauthorized user to enumerate usernames by sending a specially crafted HTTP request. IBM X-Force ID: 252293.
How severe is CVE-2023-30437?: CVE-2023-30437 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2023-30437 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-30437?: CVE-2023-30437 primarily affects Ibm Security Guardium. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-30437?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-30437 published?: CVE-2023-30437 was published on 2023-08-27 and last updated on 2026-06-17.

References

Affected products (3)

cpe:2.3:a:ibm:security_guardium:11.3:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_guardium:11.4:*:*:*:*:*:*:*
cpe:2.3:a:ibm:security_guardium:11.5:*:*:*:*:*:*:*

More vulnerabilities in Ibm Security Guardium

CVE-2023-35893 — Critical (CVSS 9.9): IBM Security Guardium 10.6, 11.3, 11.4, and 11.5 could allow a remote authenticated attacker to execute arbitrary…
CVE-2017-1253 — Critical (CVSS 9.9): IBM Security Guardium 10.0 could allow a remote authenticated attacker to execute arbitrary commands on the system. By…
CVE-2020-4690 — Critical (CVSS 9.8): IBM Security Guardium 11.3 contains hard-coded credentials, such as a password or cryptographic key, which it uses for…
CVE-2021-20418 — Critical (CVSS 9.8): IBM Security Guardium 11.2 does not require that users should have strong passwords by default, which makes it easier…
CVE-2021-20426 — Critical (CVSS 9.8): IBM Security Guardium 11.2 contains hard-coded credentials, such as a password or cryptographic key, which it uses for…
CVE-2020-4193 — Critical (CVSS 9.8): IBM Security Guardium 11.1 uses an inadequate account lockout setting that could allow a remote attacker to brute force…

All CVEs affecting Ibm Security Guardium →